The Next Big Thing In Biotech: Best CEO Candidates
Nov 16, 2012 | 5:30 AM EST - 

Adam Feuerstein, Sr. Columnist for TheStreet, is assembling candidates for the Best Biotech CEO of 2012 award.

Columnist Conversations

As you know, all of my questions are respectful- I am trying to understand squaring aggressive option position...
Bobby Thanks for clarifying your strategy in Columnist Conversation -- that was sort of one of my primary poin...
Here is a preview before my Monday article posts. I'm showing time resistance to this most recent rally. You...
I quoted Paul Price in an answer to a question from this week's Live Q&A Chat on TradingWithCody.


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.